Markets:

Overview

News

Currencies

International

Treasuries

HEALTHCARE (NY:XLV)

151.54 +3.99 (+2.70%)

Streaming Delayed Price Updated: 1:56 PM EDT, Jun 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

42 43 Next >

2023 Midyear Review Of Index ETFs And Smart Beta Strategies & A Tribute To Harry Markowitz ↗

July 11, 2023

A review and analysis of the first 6 months of 2023 using benchmark ETFs, Sector ETFs, and Smart Beta ETFs and what is likely to follow next.

Via Talk Markets

Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi

July 10, 2023

Biogen's shares decline after approval of Alzheimer's treatment Leqembi, which modestly slows cognitive decline. Analysts see hurdles to the rollout.

Via MarketBeat

Thoughts For Thursday: Back From The Holiday With Caution ↗

July 06, 2023

Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.

Via Talk Markets

$1 Billion Deal For Moderna To Expand Product Pipeline in China

July 06, 2023

Moderna is looking to diversify its falling U.S. product line, a $1 billion investment in China may act as the catalyst pushing the company's valuation higher

Via MarketBeat

Topics ETFs Economy

Bullish Action: Chipotle, Visa, Stryker Break Through Resistance

July 06, 2023

Chipotle, Visa, and Stryker recently broke out of chart bases, and remain in buy range on strong fundamental growth, institutional buying and analyst upgrades.

Via MarketBeat

Biotech Blues: Stay Balanced Through July Earnings Season ↗

July 05, 2023

Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts.

Via Talk Markets

S&P 500 Rallies Back To Highs As Apple, Nvidia Lead, But Watch For This; Tesla Deliveries Due ↗

June 30, 2023

Many stocks flashed buy signals. But was the pullback over too quickly?

Via Investor's Business Daily

Biotech And Healthcare Stocks Lagging ↗

June 21, 2023

Healthcare is a laggard with XLV down YTD but UNH is still a core position.

Via Talk Markets

D.R. Horton, Shake Shack And A Home Construction Company Up 32% This Year: CNBC's 'Final Trades' ↗

June 21, 2023

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc.

Via Benzinga

Medical Stocks Waters, Agilent, Illumina Show Growth Potential

June 20, 2023

Medical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts.

Via MarketBeat

Countdown To ES Downleg ↗

June 18, 2023

The current rally is built on the false notion that recession has been and would be avoided, that earnings would start to rise, and that incoming data aren‘t generally bad.

Via Talk Markets

More Balanced June ↗

June 13, 2023

Heading into the month of June, stock market performance this year was a clear case of the haves and the have-nots.

Via Talk Markets

Wary Of Bull Market Chorus ↗

June 11, 2023

We‘re still in the euphoric stage of the rally that has a bit further to run, in spite of the wide Nasdaq vs. long-dated Treasury yields disconnect.

Via Talk Markets

S&P 500 Low Volatility Index May 2023 Rebalance ↗

June 09, 2023

Since the last rebalance for the S&P 500 Low Volatility Index on Feb. 17, 2023, the S&P 500 finished up 3.2% despite briefly dropping in mid-March.

Via Talk Markets

Two Charts That Can Help You See What’s To Come For The Markets ↗

June 06, 2023

While a handful of large companies have driven the stock market gains, the vast majority of stocks are down.

Via Talk Markets

Bearish Vision As Apple Tests All-Time High ↗

June 05, 2023

Apple's first new product category in 8 years is a mixed-reality headset for $3499.

Via Talk Markets

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

Corporate Bankruptcies At Levels Last Seen During The Pandemic ↗

June 01, 2023

Despite all of the mainstream talk about a strong, resilient economy, corporate bankruptcies through the first four months of 2023 came in at the highest level since 2010.

Via Talk Markets

Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption? ↗

May 30, 2023

A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers.

Via Talk Markets

Tech In Orbit ↗

May 26, 2023

Tech has led the way higher with a sharp move this week. The sector is now extremely overbought, trading 3.23 standard deviations above its 50-DMA; the fifth most overbought reading on record.

Via Talk Markets

A Good Week For The Market But A Pause In The Biotech Rally ↗

May 22, 2023

Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.

Via Talk Markets

Your Mid-May Market Update: Sector Strength And Weakness So Far In 2023 ↗

May 16, 2023

Today's session continued the ongoing theme of

Via Talk Markets

Good Odds And Odd Goods ↗

May 16, 2023

Investing is all about making money. It is the realm where you go find out where the odds are good, even if the goods are odd.

Via Talk Markets

5 Most-Loved ETFs Of Last Week ↗

May 09, 2023

Last week was marked by volatility. Overall, ETFs pulled in a modest $260 million in capital for the week, bringing total inflows of $111.7 billion year to date.

Via Talk Markets

Something Happened In Biotech Last Week ↗

May 08, 2023

Biotech stocks were more constructive last week with some sharp moves up.

Via Talk Markets

Seasonal Mid Point ↗

May 05, 2023

The next three months, which is the period straddling the back half of spring and the first half of summer, has been relatively strong in the last ten years.

Via Talk Markets

Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales

May 05, 2023

Regeneron reported better-than-expected Q1 earnings and revenue, but its Eylea sales fell, losing ground to Roche's newly launched Vabysmo.

Via MarketBeat

6 Best Healthcare Stocks to Buy Right Now

April 25, 2023

Whether you invest in healthcare stocks for pharmaceuticals, medical devices or health insurance, the opportunities are limitless. Learn more with MarketBeat.

Via MarketBeat

Topics Economy Intellectual Property

Healthcare Sector Update: MedTech Trending Up ↗

April 20, 2023

Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market.

Via Talk Markets

Healthcare Innovation Drives Medical Device Makers To New Highs

April 17, 2023

Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base.

Via MarketBeat

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.